Downloads: 197

Files in This Item:
File Description SizeFormat 
14_0159.pdf332.25 kBAdobe PDFView/Open
Title: Ubretidの神経因性膀胱に対する効果および血清β-Glucuronidaseにおよぼす影響
Other Titles: Clinical evaluation of Ubretid on neurogenic bladder dysfunction and on high serum beta-glucuronidase
Authors: 近藤, 賢  KAKEN_name
内藤, 政男  KAKEN_name
杉浦, 啓之  KAKEN_name
Author's alias: Kondo, Masaru
Naito, Masao
Sugiura, Keiji
Keywords: Glucuronidase/blood
Parasympathomimetics/therapeutic use
Pyridines/therapeutic use
Spinal Cord Injuries/complications
Urinary Bladder, Neurogenic/drug therapy
Issue Date: Feb-1968
Publisher: 京都大学医学部泌尿器科学教室
Journal title: 泌尿器科紀要
Volume: 14
Issue: 2
Start page: 159
End page: 163
Abstract: Clinical effects of Ubretid on neurogenic bladder dysfunction were evaluated by cystoadaptometry. Oral administration of Ubretid 5 mg daily for 3 weeks made the hypotonic and the hypertonic bladders to be normotonic in several cases. This is the noteworthy merit of Ubretid distinguished from bethanechol chloride, which could not alter the hypertonic bladder toward normotonic. In many traumatic paraplegics (30 in 49), the serum p-glucuronidase activities were high, over 300 pgjdljhr. This finding was considered as a sign suggesting of abnormal sugar metabolism in this disorders. By oral administration of Ubretid 5 mg daily for a week the high serum p-glucuronidase activities in traumatic paraplegics were reduced to normal in many cases (7 in 12). Diagnostic value of high serum p-glucuronidase in traumatic paraplegics, and therapeutic value to reduce the high serum p-glucuronidase to normal were still entirely unknown.
PubMed ID: 5692624
Appears in Collections:Vol.14 No.2

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.